The 2020 ALS ONE Symposium is Going Virtual!
Â
ALS ONE's annual ALS ONE Research Symposium, hosted by Drs. Robert Brown, James Berry, Merit Cudkowicz, and Steve Perrin of ALS ONE, brings together researchers and scientists who are working on therapeutic options, and ultimately a cure, for Amyotrophic Lateral Sclerosis (ALS). This year’s topics are comprised of some of the most exciting updates on new and important disease topics in ALS, including:
-Â From Sporadic ALS (SALS) to Familial ALS (FALS): New biology and therapeutic opportunities.
-Â New insights into axonal trafficking and MN's.
- Updates from industry
-Â HEALEY ALS Platform Trial updates roundtable discussion.
November 4-5, 2020 10:30am-3:30pm EST each day |Â Open to all ALS researchers and scientists.
Attendance is free | Registration is required.
ALS ONEÂ is a partnership bringing together world-leading ALS researchers, doctors, and care practitioners focused on finding treatments for ALS and novel approaches to improve care and quality of life for those battling the disease. The unprecedented linking of minds and resources from Massachusetts General Hospital (MGH), University of Massachusetts Medical Center, ALS Therapy Development Institute (ALS TDI), and Compassionate Care ALS (CCALS) is unique for its leadership in efficiency, dedication to innovative research, and commitment to increasing access to care and treatment.
ALS ONE's partnership includes: Dr. Merit Cudkowicz, MD, MSc, Chief of Neurology, Massachusetts General Hospital (MGH); Dr. Robert Brown Jr., MD, DPhil, Chief of Neurology, UMass Medical Center; Dr. Steve Perrin, Ph.D., Chief Science Officer, ALS Therapy Development Institute; Dr. James Berry, MD, Co-Director of the MGH Neuromuscular Division and of the MGH ALS Unit; and Ron Hoffman, Founder and Director Compassionate Care ALS (CCALS).
Â
Learn more about ALS ONE online at ALS ONE.org